drwael_bw-2-u14726.png

President and CEO of Healthcare Development Holding Company (HDH) the healthcare arm of the Saudi Binladen  Group, which  has six subsidiary companies and five international affiliations that are specialized in various healthcare Focused businesses with projects in Saudi Arabia and the region.

Chairman of the Board

Dr. Wael Kaawach

Eiad.jpg

A well-versed executive with over 18 years of diverse experience in Pharma and Healthcare, passionate about transforming the practice and delivery of healthcare by adopting holistic prospects and developing innovative solutions. Apart from being a board member in Sudair Pharma, Mr. Al Saba is leading the group business development activities in the Healthcare Development Holding Company.

Board Member

Mr. Eiad Al Saba

Dr.Yasser_edited.png

Dr. Yasser is leading SPC Executive Team as CEO of the company, Dr. Yasser was the Director General for Executive Affairs, Security Forces Hospital Program Riyadh, Board Member SAQR "Saudi Scientific Association for Quality Performance & RisR Management in Healthcare Organization" Al Osool Medical Company CEO, and Medical Legal Consultant CPC "Continuous Pioneering Consulting Office".

Chief Executive Officer

Dr. Yasser AlObaida

Dr.Yasser_edited.png

Dr. Yasser is leading SPC Executive Team as CEO of the company, Dr. Yasser was the Director General for Executive Affairs, Security Forces Hospital Program Riyadh, Board Member SAQR "Saudi Scientific Association for Quality Performance & RisR Management in Healthcare Organization" Al Osool Medical Company CEO, and Medical Legal Consultant CPC "Continuous Pioneering Consulting Office".

Chief Executive Officer

Dr. Yasser AlObaida

  • LinkedIn - Grey Circle
  • Facebook
  • Twitter
  • Instagram

Copyright © 2019 Sudair Pharma - All Rights Reserved.